News
Medpage Today on MSN1d
RNA-Targeted Drug Approved for Preventing Hereditary Angioedema Attacks
In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...
Vanda claims that two generics to its sleep disorder drug Hetlioz were approved despite inadequate data and is requesting ...
The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' oral medication for a rare genetic disorder ...
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...
After a more than decadelong process to bring the experimental drug elamipretide to market, the treatment’s approval has ...
US regulators sent seemingly mixed messages this month about the outlook for animal-derived, or desiccated, thyroid medicines ...
IRVINE, CA / ACCESS Newswire / August 20, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of deep venous ...
The FDA’s recent issue of five warning letters to brands illegally marketing whipped, mousse and foam sunscreen products ...
Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...
IFLScience on MSN2d
COVID-19 “Vaccine Alternative” Injection Could Be On Fast-Track To Approval From FDA
Developers Invivyd, Inc. are working on a plan with the FDA that will see their antibody-based product approved if it passes ...
The original NDA submission included data from the registration-directed phase 3 MOVE-FA trial as well as 2 long-term studies evaluating vatiquinone in FA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback